Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Patient participation in ERS guidelines and research projects: the EMBARC experience.

Chalmers JD, Timothy A, Polverino E, Almagro M, Ruddy T, Powell P, Boyd J.

Breathe (Sheff). 2017 Sep;13(3):194-207. doi: 10.1183/20734735.009517. Review.

2.

European Respiratory Society guidelines for the management of adult bronchiectasis.

Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, Murris M, Cantón R, Torres A, Dimakou K, De Soyza A, Hill AT, Haworth CS, Vendrell M, Ringshausen FC, Subotic D, Wilson R, Vilaró J, Stallberg B, Welte T, Rohde G, Blasi F, Elborn S, Almagro M, Timothy A, Ruddy T, Tonia T, Rigau D, Chalmers JD.

Eur Respir J. 2017 Sep 9;50(3). pii: 1700629. doi: 10.1183/13993003.00629-2017. Print 2017 Sep.

PMID:
28889110
3.

Mental health in mass gatherings.

Khan SA, Chauhan VS, Timothy A, Kalpana S, Khanam S.

Ind Psychiatry J. 2016 Jul-Dec;25(2):216-221. doi: 10.4103/ipj.ipj_15_17.

4.

ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza.

Timothy AA, Tokanovic A, Snibson KJ, Edwards SJ, Pearse MJ, Scheerlinck JP, Sutton P.

Hum Vaccin Immunother. 2015;11(2):377-85. doi: 10.4161/21645515.2014.990859.

5.

A 54-year-old woman with pancytopenia.

Timothy AD, Jegalian A, Lichtin AE.

Cleve Clin J Med. 2011 Dec;78(12):815-20. doi: 10.3949/ccjm.78a.11061. No abstract available.

PMID:
22135271
6.

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR.

Ann Oncol. 2005 Sep;16(9):1514-23. Epub 2005 Jun 24.

PMID:
15980161
7.

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR.

Ann Oncol. 2005 Jul;16(7):1160-8. Epub 2005 Jun 6.

PMID:
15939713
8.

2-Fluorine-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography in the Pretreatment Staging of Hodgkin's Disease.

Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G.

Clin Positron Imaging. 1999 Nov;2(6):323. No abstract available.

PMID:
14516620
9.

A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit.

Schiller NK, Timothy AM, Aurora HS, Chen IL, Coy DH, Murphy WA, Akers DL, Fonseca VA, Kadowitz PJ, McNamara DB.

Mol Cell Biochem. 2002 Nov;240(1-2):31-7.

PMID:
12487369
10.

A study of vascular wound healing in a rabbit model of type I diabetes.

Schiller NK, Akers DL, Burke B, Timothy AM, Bedi B, McNamara DB.

Adv Exp Med Biol. 2001;498:87-96. No abstract available.

PMID:
11900406
11.

Radiotherapy for inoperable lung cancer.

Timothy AR, Girling DJ, Saunders MI, Macbeth F, Hoskin PJ; Second Workshop on Palliative Radiotherapy and Symptom Control.

Clin Oncol (R Coll Radiol). 2001;13(2):86-7. Review. No abstract available.

PMID:
11373884
12.

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.

Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN.

Leuk Lymphoma. 2000 Nov;39(5-6):543-53.

PMID:
11342337
13.
14.

The surgical treatment of metastatic disease of the spine.

Hatrick NC, Lucas JD, Timothy AR, Smith MA.

Radiother Oncol. 2000 Sep;56(3):335-9.

PMID:
10974383
15.

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.

Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA.

Br J Cancer. 2000 Oct;83(7):863-9.

16.

Fluorodeoxyglucose PET in the initial staging of germ cell tumours.

Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA.

Eur J Nucl Med. 2000 May;27(5):590-4.

PMID:
10853816
17.

18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas.

Mikhaeel NG, Timothy AR, Hain SF, O'Doherty MJ.

Ann Oncol. 2000;11 Suppl 1:147-50.

PMID:
10707798
18.

Adrenomedullin Does Not Inhibit Human Platelet Aggregation.

Schiller NK, Champion HC, Hugghins SY, Timothy AM, Murphy WA, Coy DH, Peter JR, Kadowitz PJ, McNamara DB.

J Cardiovasc Pharmacol Ther. 1998 Jul;3(3):223-228.

PMID:
10684501
19.

Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits.

Schiller NK, Timothy AM, Chen IL, Rice JC, Akers DL, Kadowitz PJ, McNamara DB.

Am J Physiol. 1999 Aug;277(2):H740-8. doi: 10.1152/ajpheart.1999.277.2.H740.

PMID:
10444501
20.

Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases.

Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR.

Radiother Oncol. 1998 Jun;47(3):233-40.

PMID:
9681885
21.

PET scanning in clinical oncology.

Timothy AR, Cook GJ.

Ann Oncol. 1998 Apr;9(4):353-5. Review. No abstract available.

PMID:
9636824
22.

Detection of lymphoma in bone marrow by whole-body positron emission tomography.

Carr R, Barrington SF, Madan B, O'Doherty MJ, Saunders CA, van der Walt J, Timothy AR.

Blood. 1998 May 1;91(9):3340-6.

23.

Hypofractionated radiotherapy for invasive bladder cancer.

Scholten AN, Leer JW, Collins CD, Wondergem J, Hermans J, Timothy A.

Radiother Oncol. 1997 May;43(2):163-9.

PMID:
9192962
24.

Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma.

Sawyer EJ, Timothy AR.

Radiother Oncol. 1997 Jan;42(1):49-51.

PMID:
9132826
25.

Heating characteristics of a 434 MHz transurethral system for the treatment of BPH and interstitial thermometry.

Venn SN, Hughes SW, Montgomery BS, Timothy A.

Int J Hyperthermia. 1996 Mar-Apr;12(2):271-8.

PMID:
8926394
26.

Stress at work for the clinical oncologist.

Ramirez AJ, Graham J, Richards MA, Timothy AR.

Clin Oncol (R Coll Radiol). 1996;8(3):137-9. No abstract available.

PMID:
8814366
27.

Burnout and psychiatric disorder among cancer clinicians.

Ramirez AJ, Graham J, Richards MA, Cull A, Gregory WM, Leaning MS, Snashall DC, Timothy AR.

Br J Cancer. 1995 Jun;71(6):1263-9.

28.

Computer planning of stereotactic iodine-125 seed brachytherapy for recurrent malignant gliomas.

Hughes SW, Sofat A, Kitchen ND, Brown A, Beaney RP, Timothy AR, Saunders JE, Thomas DG.

Br J Radiol. 1995 Feb;68(806):175-81.

PMID:
7537597
30.

Treatment for lung cancer: who decides?

Timothy AR.

Clin Oncol (R Coll Radiol). 1993;5(2):69-70. No abstract available.

PMID:
8386936
31.

Audit: the use of radiotherapy for NSCLC in the UK.

Maher EJ, Timothy A, Squire CJ, Goodman A, Karp SJ, Paine CH, Ryall R, Read G.

Clin Oncol (R Coll Radiol). 1993;5(2):72-9.

PMID:
7683203
32.

Response of cyclophosphamide-resistant Wegener's granulomatosis to etoposide.

D'Cruz D, Payne H, Timothy A, Hughes GR.

Lancet. 1992 Aug 15;340(8816):425-6. No abstract available.

PMID:
1353574
33.

Appropriate chemotherapy for palliating advanced cancer.

Rubens RD, Towlson KE, Ramirez AJ, Coltart S, Slevin ML, Terrell C, Timothy AR.

BMJ. 1992 Jan 4;304(6818):35-40. Review. No abstract available.

34.

Malignant lymphoma in systemic rheumatic diseases. A report of five cases.

Houssiau FA, Kirkove C, Asherson RA, Hughes GR, Timothy AR.

Clin Exp Rheumatol. 1991 Sep-Oct;9(5):515-8.

PMID:
1954702
36.

DNA flow cytometry of follicular non-Hodgkin's lymphoma.

Macartney JC, Camplejohn RS, Morris R, Hollowood K, Clarke D, Timothy A.

J Clin Pathol. 1991 Mar;44(3):215-8.

37.

Cost versus benefit in non-surgical management of patients with cancer.

Timothy AR, Brewin T, Chamberlain J, Horwich A, Jennett B, Kind P, Maxwell R, Raftery J, Rees G, Selby P, et al.

BMJ. 1988 Aug 13;297(6646):471-2. Review. No abstract available.

38.

Treatment of Hodgkin's disease.

Sutcliffe SB, Timothy AR.

Baillieres Clin Haematol. 1987 Mar;1(1):109-40. Review. No abstract available.

PMID:
3327550
39.
40.

Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).

Timothy AR, Calman FM, Bateman NT, Farebrother M, Slevin ML, Bellamy D, Rubens RD, Costello J.

Semin Oncol. 1985 Mar;12(1 Suppl 2):45-7.

PMID:
2983435
41.

A phase I clinical study of Nimorazole as a hypoxic radiosensitizer.

Timothy AR, Overgaard J, Overgaard M.

Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1765-8.

PMID:
6480460
42.

Studies of the pharmacokinetic properties of nimorazole.

Overgaard J, Overgaard M, Timothy AR.

Br J Cancer. 1983 Jul;48(1):27-34.

43.

An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group.

Fielding JW, Fagg SL, Jones BG, Ellis D, Hockey MS, Minawa A, Brookes VS, Craven JL, Mason MC, Timothy A, Waterhouse JA, Wrigley PF.

World J Surg. 1983 May;7(3):390-9. No abstract available.

PMID:
6349141
44.

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.

Overgaard J, Overgaard M, Nielsen OS, Pedersen AK, Timothy AR.

Br J Cancer. 1982 Dec;46(6):904-11.

45.

Posttreatment laparotomy as a guide to management in patients with Hodgkin's disease.

Sutcliffe SB, Wrigley PF, Timothy AR, Dorreen MA, Shand WS, Stansfeld AG, Jones AE, Malpas JS, Lister TA.

Cancer Treat Rep. 1982 Apr;66(4):759-65.

PMID:
7074646
46.

Localized non-Hodgkin's Lymphoma.

Timothy AR, Lister TA, Katz D, Jones AE.

Eur J Cancer. 1980 Jun;16(6):799-807. No abstract available.

PMID:
7408929
47.

Influence of scalp hypothermia on doxorubicin related alopecia.

Timothy AR, Bates TD, Hoy AM.

Lancet. 1980 Mar 22;1(8169):663. No abstract available.

PMID:
6102674
48.

The management of stage IIIA Hodgkin's disease.

Timothy AR, Sutcliffe SB, Lister TA, Wrigley PF, Jones AE.

Int J Radiat Oncol Biol Phys. 1980 Feb;6(2):135-42. No abstract available.

PMID:
7390887
49.

Staging in Hodgkin's disease.

Sutcliffe SB, Timothy AR, Lister TA.

Clin Haematol. 1979 Oct;8(3):593-609. Review. No abstract available.

PMID:
387318
50.

Early breast cancer.

Timothy AR, Overgaard J, Overgaard M.

Lancet. 1979 Aug 4;2(8136):258. No abstract available.

PMID:
89377

Supplemental Content

Loading ...
Support Center